Stephen Webster

Track

Insider profile

Currently holds positions in Spark Therapeutics Inc, Adolor Corp, NextCure Inc, TCR2 Therapeutics Inc and Nabriva Therapeutics PLC

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 84% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Spark Therapeutics Inc July 1, 2014 -
Chief Financial Officer, Senior Vice President - Finance Adolor Corp June 23, 2008 -
Independent Director NextCure Inc April 1, 2019 -
Independent Director TCR2 Therapeutics Inc April 30, 2020 -
Independent Member of the Supervisory Board Nabriva Therapeutics PLC Aug. 1, 2016 -
Independent Director Viking Therapeutics Inc May 1, 2014 - May 21, 2020
Stephen Webster's trades of Nabriva Therapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-04 2022-08-02
S Sale
70,722 -20.0%
295.74
US$3,864,109 		70,722 -20.0% 295.74 US$3,864,109
2021-08-04 2021-08-02
S Sale
82,392 -24.9%
47.07
US$1,809,457 		82,392 -24.9% 47.07 US$1,809,457
2018-05-31 2018-05-29
B Purchase
20,234 +38.4%
293.27
US$525,047 		20,234 +38.4% 293.27 US$525,047